New for March: Research opportunities and updates

Information on how to better control asthma and allergies for life without limits

Having trouble viewing this message? View this email in a browser. Share Tweet Forward March 2023 Research Updates   One way the Asthma and Allergy Foundation of America (AAFA) works on behalf of the more than 100 million people in the U.S. who have asthma and allergies is through research. We work with doctors, researchers, patients, caregivers, public health, and government agencies to conduct and support research that is important to people affected by asthma and allergies. As a person with asthma or allergies (or as a caregiver of someone with asthma or allergies), you can get involved in research in different ways. You can have a major impact on asthma and allergy research. Here are some of the ways you can help improve treatments, education, and awareness of asthma and allergies right now: SURVEYS Share Your Experiences with Food Allergies AAFA is collaborating on a survey with researchers at Mass General Hospital. We are looking to better understand the experiences of children and teens living with food allergies and their caregivers. You can help by taking a (10 minute) online survey about your family's life with food allergies. The results will help us create resources to improve daily life for people with food allergies and their caregivers.  SURVEY FOR CAREGIVERS SURVEY FOR TEENS INTERVIEWS AND FOCUS GROUPS Participants Needed for Adolescent Asthma Self-Management Study Researchers at Texas Woman's University want to learn more about adolescent asthma self-management. The researchers would like to understand the experiences and perspectives of adolescents living with asthma. Adolescents will have a chance to speak about their asthma control, asthma tools, and experiences. The study format will be a private interview. Interviews will take place via Zoom. Who may qualify to participate in this study? Adolescents living with asthma 12-18 years old English speaker The study participants will be given: $20 Amazon gift card Asthma resources Participation is voluntary. You can stop the sessions at any time. There is a potential risk for loss of confidentiality in all email downloading, electronic meetings, and internet transactions. If you have further questions about the study, please call Elif Isik (PhD, RN) at (713) 794-2109 or email her at eisik@twu.edu. LEARN MORE CLINICAL TRIALS Seeking Volunteers with Asthma for Paid Clinical Trial Do you or your child have asthma? Researchers are seeking volunteers for a paid, at-home research study that seeks to improve how we treat asthma. The clinical trial will study the effectiveness of a new combination albuterol-budesonide inhaler for the rapid relief of asthma symptoms and daily inflammation. Sponsored by Science37 LEARN MORE LATEST RESEARCH NEWS Asthma Routine Bronchoscopy May Help Guide Therapies for Severe Asthma   Low-Cost Device Can Measure Air Pollution Anywhere   DUPIXENT® (Dupilumab) Demonstrates Potential to Become First Biologic to Treat COPD By Showing Significant Reduction in Exacerbations in Pivotal Trial   Food Allergy Report Finds an Enormous Increase in the Number of Food Items Recalled in 2022   ARS Pharmaceuticals Announces FDA Advisory Committee for neffy® for the Treatment of Allergic Reactions (Type 1), Including Anaphylaxis   Bryn Pharma's UTULY™ 13.2mg Intranasal Epinephrine Spray Provides Enhanced PK Profile (higher and more sustained) Compared to 0.3mg Epinephrine Autoinjector (EpiPen) in Subjects with and without Nasal Congestion   Forgoing One Food Treats Eosinophilic Esophagitis (EoE) as well as Excluding Six   CSU DUPIXENT® (Dupilumab) Application for Treatment of Chronic Spontaneous Urticaria (CSU) in Adults And Adolescents Accepted for FDA Review Thank you for your continued support. Visit aafa.org, aafa.org/certified, kidswithfoodallergies.org FOLLOW US: Facebook Twitter Instagram YouTube Disclaimer: This newsletter is provided to you as a member and subscriber benefit and your use of it is in accordance with our website's terms of service. Asthma and Allergy Foundation of America makes no representation, whatsoever, for the contents that may be contained in any of the sponsors or advertisers in this newsletter or the quality of any products, information, or other materials displayed, purchased or obtained by you as a result of an offer in connection with any advertisement.  Please follow the instructions at the bottom of the newsletter to unsubscribe if you no longer wish to be on our newsletter mailing list. This newsletter is sent to all newsletter subscribers, registered members and donors of Asthma and Allergy Foundation of America. Copyright © 2023 Asthma and Allergy Foundation of America, All rights reserved. ISSN 1939-8166. You are receiving this email because you opted in at our website, registered for one of our online events, or made a donation in support of our organization. Important notice: We will never sell, rent or trade your e-mail address to any other organization. Please see our Privacy Policy.

This email was sent to edwardlorilla2001.tower2@blogger.com why did I get this?    unsubscribe from this list    update subscription preferences Asthma and Allergy Foundation of America · 1235 S Clark St · Suite 305 · Arlington, VA 22202 · USA